L3VLUP
ProSign in

TARA in the 13F filings

Protara Therapeutics Inc · CUSIP 74365U107

Sector · Pharmaceuticals and biotechnologyTheme · Biological productsTheme · Healthcare: biopharma and medtech· L3VLUP-defined
Quarter
Q3 2024Q1 2021Q4 2020Q3 2020
Quarter end
30 Sep 2020
the date the book describes
Filed
16 Nov 2020
latest of these filings; the earliest 12 Nov 2020
Managers listing it
2
at least, of 95 tracked, among listed positions
Comparable managers
91
filed both Q2 2020 and Q3 2020; 0 listed it in both
Shares listed
721,384
combined, among listed positions
Reported value
$12m
combined, at the quarter end

Managers listing TARA in Q3 2020

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q2 2020, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

2 of 2 holders

ActionFiling
Farallon Capital Management LLC425,000$7.2munder 0.1%Newnew16 Nov 2020 (the filing on sec.gov)
Artisan Partners LP296,384$5.0munder 0.1%Newnew12 Nov 2020 (the filing on sec.gov)

Largest increases and reductions, by shares

There is no earlier quarter on file to compare with.

Increases

Reductions

No reduction among listed positions.

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (2)

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
2 in Q3 2020 to 1 in Q3 2024

Tracked managers listing it, at least.

01122Q3 2020Q4 2020Q1 2021Q3 2024
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
TARA by quarter
QuarterHoldersReported valueBuyersSellers
Q3 20202$12mn.a.n.a.
Q4 20201$9.1mn.a.n.a.
Q1 20211$6.0mn.a.n.a.
Q3 20241$1.6m10

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

TARA and GILD →TARA and AMGN →TARA and ARGX →Choose a stock to compare with TARA →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own TARA, latest filings →Back to the 13F Explorer →